Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,825	3,099	4,052	4,495	13,929	6,252
Short-Term Investments	494.73	11,207	9,433	2,400	7,463	6,396
Cash & Short-Term Investments	11,319	14,306	13,485	6,895	21,392	12,649
Cash Growth	-29.21%	6.09%	95.59%	-67.77%	69.12%	-57.70%
Accounts Receivable	8,513	4,014	4,241	3,072	3,584	4,623
Other Receivables	0.55	34.96	96.49	32.52	154.82	1,001
Receivables	8,514	4,049	4,337	3,104	3,739	5,624
Inventory	9,483	4,550	8,281	9,106	6,254	4,389
Prepaid Expenses	544.29	459.29	308.51	281.85	55.4	14.22
Other Current Assets	1,010	628.87	506.67	548.41	630.85	730.2
Total Current Assets	30,870	23,992	26,918	19,936	32,071	23,406
Property, Plant & Equipment	26,789	24,568	22,764	23,152	23,904	20,983
Long-Term Investments	2,249	1,034	644.17	548.66	509.54	1,932
Goodwill	-	-	-	-	-	220.31
Other Intangible Assets	1,406	1,255	1,282	818.32	817.77	724.56
Long-Term Deferred Tax Assets	-	457.97	557.14	825.57	248.83	27.4
Other Long-Term Assets	2,820	1,597	1,030	701.66	517.12	602.47
Total Assets	64,134	52,905	53,196	45,982	58,069	47,896
Accounts Payable	812.58	837.06	1,048	861.03	1,953	1,387
Accrued Expenses	995.69	600.95	564.82	709.24	414.39	498.58
Short-Term Debt	3,935	3,675	5,875	4,942	4,735	-
Current Portion of Leases	189.57	217.95	29.73	220.38	233.33	236.73
Current Income Taxes Payable	547.98	462.79	540.81	573.6	1,449	263.54
Other Current Liabilities	2,190	490	499.72	441.35	833.07	799.12
Total Current Liabilities	8,670	6,284	8,559	7,748	9,617	3,185
Long-Term Debt	3,103	-	-	-	9,421	-
Long-Term Leases	241.16	174.56	21.89	68.78	274.54	459.18
Other Long-Term Liabilities	36.7	34.84	53.07	60.34	29.76	39.36
Total Liabilities	12,051	6,493	8,634	7,877	19,342	3,684
Common Stock	5,117	4,630	4,630	4,100	4,100	4,100
Additional Paid-In Capital	24,966	23,835	23,835	18,077	18,077	18,070
Retained Earnings	24,515	17,995	13,616	21,086	31,294	28,163
Treasury Stock	-5,030	-2,833	-37.25	-7,916	-7,916	-7,916
Comprehensive Income & Other	2,486	2,338	2,072	-3,648	-17,136	1,227
Total Common Equity	52,054	45,965	44,116	31,700	28,420	43,644
Minority Interest	28.64	-	-	-	-	121.62
Shareholders' Equity	52,083	46,412	44,563	38,105	38,726	44,213
Total Liabilities & Equity	64,134	52,905	53,196	45,982	58,069	47,896
Total Debt	7,469	4,068	5,927	5,232	14,663	695.91
Net Cash (Debt)	3,851	10,238	7,558	1,663	6,728	11,953
Net Cash Growth	-63.05%	35.46%	354.48%	-75.28%	-43.71%	-59.35%
Net Cash Per Share	461.77	1147.60	894.55	237.54	852.31	1484.50
Filing Date Shares Outstanding	9.2	8.54	9.26	7	7	7.16
Total Common Shares Outstanding	9.2	8.54	9.26	7	7	7.16
Working Capital	22,200	17,709	18,359	12,187	22,454	20,221
Book Value Per Share	5657.12	5383.59	4765.58	4527.97	4059.42	6096.97
Tangible Book Value	50,648	44,710	42,834	30,882	27,602	42,700
Tangible Book Value Per Share	5504.27	5236.55	4627.08	4411.09	3942.62	5964.98
Land	-	2,360	2,360	2,360	2,360	2,360
Buildings	-	8,986	8,442	8,459	8,282	422.5
Machinery	-	11,565	10,287	10,742	10,622	5,304
Construction In Progress	-	766.68	128.07	30.27	310.99	11,915

Source: S&P Global Market Intelligence. Standard template. Financial Sources.